Collins, and Dr. Anthony Fauci, the long-time head of the National Institute of Allergy and Infectious Diseases, were ...
Educators, researchers and students at University of Illinois Chicago rallied against proposed funding cuts from the National ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...
In July 2018, the National Institute of Allergy and Infectious Diseases (NIAID) at NIH announced that it would co-fund a major study to evaluate a type of stem cell as treatment for moderate to severe ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...